Brachial artery reactivity in patients with severe sepsis: An observational study

Critical Care

Volumn 16, Issue 2, 2012, Pages

  Wexler, Orren ^a   M Morgan, Mary A ^a   Gough, Michael S ^a   Steinmetz, Sherry D ^a   Mack, Cynthia M ^a   Darling, Denise C ^a   Doolin, Kathleen P ^a   Apostolakos, Michael J ^a   Graves, Brian T ^a   Frampton, Mark W ^a   Chen, Xucai ^b   Pietropaoli, Anthony P ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ADULT; AGED; ARTERY BLOOD FLOW; ARTICLE; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEART CYCLE; HUMAN; HYPEREMIA; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; SEPTIC SHOCK; SURVIVOR; AREA UNDER THE CURVE; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; ECHOGRAPHY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SURVIVAL RATE;

AREA UNDER CURVE; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; ROC CURVE; SEPSIS; SURVIVAL RATE;

EID: 84862786867     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11223     Document Type: Article

References (65)

1. DeBacker D, Creteur J, Preiser JC, Dubois MJ, Vincent JL. Microvascular blood flow in patients with sepsis. Am J Respir Crit Care Med 2002, 166:98-104. 10.1164/rccm.200109-016OC, 12091178.
2. Shepherd JT. Peripheral circulation and organ blood flow. Handbook of Physiology: The Cardiovascular System 1983, III:319-371. Bethesda, MD: American Physiological Society, Geiger SR, Abboud FM, Shepherd JT.
3. Kanatsuka H, Sekiguchi N, Sato K, Akai K, Wang Y, Komaru T, Ashikawa K, Takishima T. Microvascular sites and mechanisms responsible for reactive hyperemia in the coronary circulation of the beating canine heart. Circ Res 1992, 71:912-922.
4. Koller A, Kaley G. Role of endothelium in reactive dilation of skeletal muscle arterioles. Am J Physiol 1990, 259:H1313-H1316.
5. Engelke KA, Halliwill JR, Proctor DN, Dietz NM, Joyner MJ. Contribution of nitric oxide and prostaglandins to reactive hyperemia in human forearm. J Appl Physiol 1996, 81:1807-1814.
6. Carlsson I, Sollevi A, Wennmalm A. The role of myogenic relaxation, adenosine and prostaglandins in human forearm reactive hyperaemia. J Physiol (Lond) 1987, 389:147-161.
7. Meredith IT, Currie KE, Anderson TJ, Roddy MA, Ganz P, Creager MA. Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol 1996, 270:H1435-H1440.
8. Neviere R, Mathieu D, Chagnon JL, Lebleu N, Millien JP, Wattel F. Skeletal muscle microvascular blood flow and oxygen transport in patients with severe sepsis. Am J Respir Crit Care Med 1996, 153:191-195.
9. Hartl WH, Gunther B, Inthorn D, Heberer G. Reactive hyperemia in patients with septic conditions. Surgery 1988, 103:440-444.
10. Astiz ME, DeGent GE, Lin RY, Rackow EC. Microvascular function and rheologic changes in hyperdynamic sepsis. Crit Care Med 1995, 22:265-271.
11. Astiz ME, Tilly E, Rackow ED, Weil MH. Peripheral vascular tone in sepsis. Chest 1991, 99:1072-1075. 10.1378/chest.99.5.1072, 2019159.
12. Anderson TJ, Charbonneau F, Title LM, Buithieu J, Rose MS, Conradson H, Hildebrand K, Fung M, Verma S, Lonn EM. Microvascular function predicts cardiovascular events in primary prevention: long-term results from the Firefighters and Their Endothelium (FATE) study. Circulation 2011, 123:163-169. 10.1161/CIRCULATIONAHA.110.953653, 21200002.
13. Huang AL, Silver AE, Shvenke E, Schopfer DW, Jahangir E, Titas MA, Shpilman A, Menzoian JO, Watkins MT, Raffetto JD, Gibbons G, Woodson J, Shaw PM, Dhadly M, Eberhardt RT, Keaney JF, Gokce N, Vita JA. Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery. Arterioscler Thromb Vasc Biol 2007, 27:2113-2119. 10.1161/ATVBAHA.107.147322, 2596307, 17717291.
14. Philpott AC, Lonn E, Title LM, Verma S, Buithieu J, Charbonneau F, Anderson TJ. Comparison of new measures of vascular function to flow mediated dilatation as a measure of cardiovascular risk factors. Am J Cardiol 2009, 103:1610-1615. 10.1016/j.amjcard.2009.01.376, 19463524.
15. Vita JA, Keaney JF, Larson MG, Keyes MJ, Massaro JM, Lipinska I, Lehman BT, Fan S, Osypiuk E, Wilson PWF, Vasan RS, Mitchell GF, Benjamin EJ. Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study. Circulation 2004, 110:3604-3609. 10.1161/01.CIR.0000148821.97162.5E, 15569842.
16. Widlansky ME, Vita JA, Keyes MJ, Larson MG, Hamburg NM, Levy D, Mitchell GF, Osypiuk EW, Vasan RS, Benjamin EJ. Relation of season and temperature to endothelium-dependent flow-mediated vasodilation in subjects without clinical evidence of cardiovascular disease (from the Framingham Heart Study). Am J Cardiol 2007, 100:518-523. 10.1016/j.amjcard.2007.03.055, 1994775, 17659939.
17. Philpott A, Anderson TJ. Reactive hyperemia and cardiovascular risk. Arterioscler Thromb Vasc Biol 2007, 27:2065-2067. 10.1161/ATVBAHA.107.149740, 17881738.
18. Skarda DE, Mulier KE, Myers DE, Taylor JH, Beilman GJ. Dynamic near-infrared spectroscopy measurements in patients with severe sepsis. Shock 2007, 27:348-353. 10.1097/01.shk.0000239779.25775.e4, 17414414.
19. Young JD, Cameron EM. Dynamics of skin blood flow in human sepsis. Intensive Care Med 1995, 21:669-674. 10.1007/BF01711546, 8522672.
20. Davis JS, Yeo TW, Thomas JH, McMillan M, Darcy CJ, McNeil YR, Cheng AC, Celermajer DS, Stephens DP, Anstey NM. Sepsis-associated microvascular dysfunction measured by peripheral arterial tonometry: an observational study. Critical Care (Lond) 2009, 13:R155.
21. Haisjackl M, Hasibeder W, Klaunzer S, Altenberger H, Koller W. Diminished reactive hyperemia in the skin of critically ill patients. Crit Care Med 1990, 18:813-818. 10.1097/00003246-199008000-00003, 2379393.
22. Doerschug KC, Delsing AS, Schmidt GA, Haynes WG. Impairments in microvascular reactivity are related to organ failure in human sepsis. Am J Physiol Heart Circ Physiol 2007, 293:H1065-H1071. 10.1152/ajpheart.01237.2006, 17483235.
23. Creteur J, Carollo T, Soldati G, Buchele G, De Backer D, Vincent JL. The prognostic value of muscle StO2 in septic patients. Intensive Care Med 2007, 33:1549-1556. 10.1007/s00134-007-0739-3, 17572876.
24. Shapiro NL, Arnold RC, Sherwin R, O'Connor J, Najarro G, Singh S, Lundy D, Nelson T, Trzeciak SW, Jones AE. The association of near-infrared spectroscopy-derived tissue oxygen measurements with sepsis syndromes, organ dysfunction and mortality in emergency department patients with sepsis. Critical Care 2011, 15:R223. 10.1186/cc10463, 21939529.
25. Trzeciak S, Cinel I, Dellinger P, Shapiro NI, Arnold RC, Parrillo JE, Hollenberg SM. Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials. Acad Emerg Med 2008, 15:399-413. 10.1111/j.1553-2712.2008.00109.x, 2727641, 18439194.
26. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002, 39:257-265.
27. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, Luscher TF. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995, 91:1314-1319.
28. Luiking YC, Poeze M, Ramsay G, Deutz NEP. Reduced citrulline production in sepsis is related to diminished de novo arginine and nitric oxide production. Am J Clin Nutr 2009, 89:142-152.
29. Gough MS, Morgan MAM, Mack CM, Darling DC, Frasier LM, Doolin KP, Apostolakos MJ, Stewart JC, Graves BT, Arning E, Bottiglieri T, Mooney RA, Frampton MW, Pietropaoli AP. The ratio of arginine to dimethylarginines is reduced and predicts outcomes in patients with severe sepsis. Crit Care Med 2011, 39:1351-1358. 10.1097/CCM.0b013e318212097c, 21378552.
30. Morgan MM, Frasier LM, Stewart JC, Mack CM, Gough MS, Graves BT, Apostolakos MJ, Doolin KP, Darling DC, Frampton MW, Pietropaoli AP. Artery-to-vein differences in nitric oxide metabolites are diminished in sepsis. Crit Care Med 2010, 38:1069-1077. 10.1097/CCM.0b013e3181d16a3e, 20081526.
31. Vaudo G, Marchesi S, Siepi D, Brozzetti M, Lombardini R, Pirro M, Alaeddin A, Roscini AF, Lupattelli G, Mannarino E. Human endothelial impairment in sepsis. Atherosclerosis 2008, 197:747-752. 10.1016/j.atherosclerosis.2007.07.009, 17765247.
32. Thijssen DHJ, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA, Parker B, Widlansky ME, Tschakovsky ME, Green DJ. Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol 300:H2-H12. [Au Query: Please provide year.].
33. Morgan MM, Stewart JC, Mack CM, Graves BT, Frasier LM, Steinmetz SD, Doolin KP, Darling DC, Apostolakos MJ, Frampton MW, Pietropaoli AP. Flow-mediated brachial artery dilation is impaired in sepsis syndrome. Am J Respir Crit Care Med 2008, 177:A118.
34. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622.
35. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Statist Assoc 1958, 53:457-481.
36. Bernard GR, Wheeler AP, Arons MM, Morris PE, Paz HL, Russell JA, Wright PE. A trial of antioxidants N-acetylcysteine and procysteine in ARDS: the Antioxidant in ARDS Study Group. Chest 1997, 112:164-172. 10.1378/chest.112.1.164, 9228372.
37. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med 1985, 13:818-829. 10.1097/00003246-198510000-00009, 3928249.
38. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure: On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710. 10.1007/BF01709751, 8844239.
39. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992, 340:1111-1115. 10.1016/0140-6736(92)93147-F, 1359209.
40. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383. 10.1016/0021-9681(87)90171-8, 3558716.
41. Celermajer DS, Sorensen KE, Bull CM, Robinson J, Deanfield JE. Endothelium dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994, 24:468-474.
42. Matthews JN, Altman DG. Interaction 3: how to examine heterogeneity. BMJ 1996, 313:862. 10.1136/bmj.313.7061.862, 2359064, 8870577.
43. Afifi A, Clark VA, May S. Computer-aided Multivariate Analysis 2004, Boca Raton: Chapman & Hall/CRC Press, 4.
44. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845. 10.2307/2531595, 3203132.
45. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1:307-310.
46. McGinn T, Wyer PC, Newman TB, Keitz S, Leipzig R, Guyatt G. Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic).[Erratum appears in CMAJ 2005, 173:18]. CMAJ 2004, 171:1369-1373. 10.1503/cmaj.1031981, 527344, 15557592.
47. Spronk PE, Zandstra DF, Ince C. Bench-to-bedside review: sepsis is a disease of the microcirculation. Crit Care (London) 2004, 8:462-468.
48. Heyland DK, Dhaliwal R, Suchner U, Berger MM. Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med 2005, 31:327-337. 10.1007/s00134-004-2522-z, 15605227.
49. Tousoulis D, Antoniades C, Tentolouris C, Tsioufis C, Toutouza M, Toutouzas P, Stefanadis C. Effects of combined administration of vitamins C and E on reactive hyperemia and inflammatory process in chronic smokers. Atherosclerosis 2003, 170:261-267. 10.1016/S0021-9150(03)00250-8, 14612206.
50. Spronk PE, Ince C, Gardien MJ, Mathura KR, Oudemans-van Straaten HM, Zandstra DF. Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 2002, 360:1395-1396. 10.1016/S0140-6736(02)11393-6, 12423989.
51. Angus DC. Caring for the critically ill patient: challenges and opportunities. JAMA 2007, 298:456-458. 10.1001/jama.298.4.456, 17652301.
52. Cohen J, Guyatt G, Bernard GR, Calandra T, Cook D, Elbourne D, Marshall J, Nunn A, Opal S. New strategies for clinical trials in patients with sepsis and septic shock. Crit Care Med 2001, 29:880-886. 10.1097/00003246-200104000-00039, 11373487.
53. Kirschenbaum LA, Astiz ME, Rackow EC, Saha DC, Lin R. Microvascular response in patients with cardiogenic shock. Crit Care Med 2000, 28:1290-1294. 10.1097/00003246-200005000-00005, 10834667.
54. Johnson JM, Taylor WF, Shepherd AP, Park MK. Laser-Doppler measurement of skin blood flow: comparison with plethysmography. J Appl Physiol 1984, 56:798-803. 10.1063/1.334009, 6706783.
55. Nohria A, Gerhard-Herman M, Creager MA, Hurley S, Mitra D, Ganz P, Nohria A, Gerhard-Herman M, Creager MA, Hurley S, Mitra D, Ganz P. Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol 2006, 101:545-548. 10.1152/japplphysiol.01285.2005, 16614356.
56. De Blasi RA, Ferrari M, Natali A, Conti G, Mega A, Gasparetto A. Noninvasive measurement of forearm blood flow and oxygen consumption by near-infrared spectroscopy. J Appl Physiol 1994, 76:1388-1393.
57. Brennan JM, Blair JE, Hampole C, Goonewardena S, Vasaiwala S, Shah D, Spencer KT, Schmidt GA. Radial artery pulse pressure variation correlates with brachial artery peak velocity variation in ventilated subjects when measured by internal medicine residents using hand-carried ultrasound devices. Chest 2007, 131:1301-1307. 10.1378/chest.06-1768, 17494781.
58. Tschakovsky ME, Shoemaker JK, Hughson RL. Beat-by-beat forearm blood flow with Doppler ultrasound and strain-gauge plethysmography. J Appl Physiol 1995, 79:713-719.
59. Green S, Thorp R, Reeder EJ, Donnelly J, Fordy G, Green S. Venous occlusion plethysmography versus Doppler ultrasound in the assessment of leg blood flow during calf exercise. Eur J Appl Physiol 111:1889-1900. [Au Query: Please provide year.].
60. Schmidt GA. ICU ultrasound: the coming boom. Chest 2009, 135:1407-1408. 10.1378/chest.09-0502, 19497889.
61. Witte DR, Westerink J, de Koning EJ, van der Graaf Y, Grobbee DE, Bots ML. Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations?. J Am Coll Cardiol 2005, 45:1987-1993. 10.1016/j.jacc.2005.02.073, 15963397.
62. Hijmering ML, Stroes ESG, Olijhoek J, Hutten BA, Blankestijn PJ, Rabelink TJ. Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation. J Am Coll Cardiol 2002, 39:683-688. 10.1016/S0735-1097(01)01786-7, 11849869.
63. Benjamin EJ, Larson MG, Keyes MJ, Mitchell GF, Vasan RS, Keaney JF, Lehman BT, Fan S, Osypiuk E, Vita JA. Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation 2004, 109:613-619. 10.1161/01.CIR.0000112565.60887.1E, 14769683.
64. Duffy MJ, Mullan BA, Craig TR, Shyamsundar M, MacSweeney RE, Thompson G, Stevenson M, McAuley DF. Impaired endothelium-dependent vasodilatation is a novel predictor of mortality in intensive care. Crit Care Med 2011, 39:629-635. 10.1097/CCM.0b013e318206bc4a, 21242802.
65. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steinbrub JS, Garber GE, Helterbrand JD, Ely W, Fisher CJ. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344:699-709. 10.1056/NEJM200103083441001, 11236773.